Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Lantus
Pharma
Sanofi gains FDA nod for first biosimilar version of NovoLog
The FDA has given a thumbs up to Sanofi’s Merilog as the first biosimilar substitute for Novo Nordisk’s NovoLog for patients with diabetes.
Kevin Dunleavy
Feb 18, 2025 11:05am
FTC takes patent scrutiny to Sanofi, Mylan's insulin case
Nov 21, 2023 11:34am
Civica Rx draws $50M from California to produce low-cost insulin
Mar 20, 2023 11:45am
Bernie Sanders calls out Sanofi, Novo Nordisk for insulin prices
Mar 3, 2023 11:52am
FDA rejects Biocon biosimilar over data, manufacturing concerns
Jan 12, 2023 8:25am
Viatris kicked off its third insulin biosim recall this year
Jul 6, 2022 9:08am
